Published in Blood Weekly, June 13th, 2002
Higher filgrastim doses produced higher stem cell yields but increased the severity of G-CSF-associated side effects as well, Kroeger and coauthors found.
The researchers administered 10 (mu)g/kg of filgrastim...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.